{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:41:28Z","timestamp":1791268888016,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,7,5]],"date-time":"2014-07-05T00:00:00Z","timestamp":1404518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s11926-014-0433-8","type":"journal-article","created":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T02:59:00Z","timestamp":1404442740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Is Statin-Induced Myositis Part of the Polymyositis Disease Spectrum?"],"prefix":"10.1007","volume":"16","author":[{"given":"Jemima","family":"Albayda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Mammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,5]]},"reference":[{"issue":"7","key":"433_CR1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344\u20137.","journal-title":"N Engl J Med"},{"issue":"8","key":"433_CR2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403\u20137.","journal-title":"N Engl J Med"},{"issue":"5","key":"433_CR3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","volume":"14","author":"JE Hoogendijk","year":"2004","unstructured":"Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, et al. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004;14(5):337\u201345.","journal-title":"Neuromuscul Disord"},{"issue":"21","key":"433_CR4","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"M Dalakas","year":"1991","unstructured":"Dalakas M. Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med. 1991;325(21):1487\u201398.","journal-title":"N Engl J Med"},{"issue":"6","key":"433_CR5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","volume":"314","author":"JT Kissel","year":"1986","unstructured":"Kissel JT, Mendell JR, Rammohan KW. Microvascular Deposition of Complement Membrane Attack Complex in Dermatomyositis. N Engl J Med. 1986;314(6):329\u201334.","journal-title":"N Engl J Med"},{"issue":"2","key":"433_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","volume":"16","author":"K Arahata","year":"1984","unstructured":"Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol. 1984;16(2):193\u2013208.","journal-title":"Ann Neurol"},{"issue":"3","key":"433_CR7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0046-8177(89)90128-7","volume":"20","author":"A Emslie-Smith","year":"1989","unstructured":"Emslie-Smith A, Arahata K, Engel AG. Major histocompatibility complex class 1 antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol. 1989;20(3):224\u201331.","journal-title":"Hum Pathol"},{"issue":"4","key":"433_CR8","first-page":"668","volume":"22","author":"K Tanimoto","year":"1995","unstructured":"Tanimoto K, Nakano K, Kano S, Mori S, Ueki H, Nishitani H, et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol. 1995;22(4):668\u201374.","journal-title":"J Rheumatol"},{"issue":"5","key":"433_CR9","first-page":"767","volume":"31","author":"H Linklater","year":"2013","unstructured":"Linklater H, Pipitone N, Rose M, Norwood F, Campbell R, Salvarani C, et al. Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria. Clin Exp Rheumatol. 2013;31(5):767\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"433_CR10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MD.0b013e31827ebba1","volume":"92","author":"C Fernandez","year":"2013","unstructured":"Fernandez C, Bardin N, De Paula AM, Salort-Campana E, Benyamine A, Franques J, et al. Correlation of Clinicoserologic and Pathologic Classifications of Inflammatory Myopathies: Study of 178 Cases and Guidelines for Diagnosis. Medicine (Baltimore). 2013;92(1):15\u201324.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"433_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","volume":"84","author":"Y Troyanov","year":"2005","unstructured":"Troyanov Y, Targoff IN, Tremblay J-L, Goulet J-R, Raymond Y, Senecal J-L. Novel Classification of Idiopathic Inflammatory Myopathies Based on Overlap Syndrome Features and Autoantibodies: Analysis of 100 French Canadian Patients. Medicine (Baltimore). 2005;84(4):231\u201349.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"433_CR12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002281-199711000-00008","volume":"9","author":"IN Targoff","year":"1997","unstructured":"Targoff IN, Miller FW, Medsger TA, Oddis CV. Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol. 1997;9(6):527\u201335.","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"433_CR13","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.ajpath.2012.08.033","volume":"181","author":"C Preu\u00dfe","year":"2012","unstructured":"Preu\u00dfe C, Goebel HH, Held J, Wengert O, Scheibe F, Irlbacher K, et al. Immune-Mediated Necrotizing Myopathy Is Characterized by a Specific Th1-M1 Polarized Immune Profile. Am J Pathol. 2012;181(6):2161\u201371. This study demonstrated that a difference in cellular and molecular characteristics can distinguish immune-mediated necrotizing myopathies from non-immune-mediated necrotizing myopathies.","journal-title":"Am J Pathol"},{"issue":"6","key":"433_CR14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/01.bor.0000434664.37880.ac","volume":"25","author":"SL Tansley","year":"2013","unstructured":"Tansley SL, Betteridge ZE, McHugh NJ. The diagnostic utility of autoantibodies in adult and juvenile myositis. Curr Opin Rheumatol. 2013;25(6):772\u20137.","journal-title":"Curr Opin Rheumatol"},{"key":"433_CR15","doi-asserted-by":"crossref","unstructured":"Ghirardello A, Bassi N, Palma L, Borella E, Domeneghetti M, Punzi L, et al. Autoantibodies in Polymyositis and Dermatomyositis. Curr Rheumatol Rep [Internet]. 2013. [cited 2014 May 21];15(6). Available from: 10.1007\/s11926-013-0335-1","DOI":"10.1007\/s11926-013-0335-1"},{"issue":"7","key":"433_CR16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.6061\/clinics\/2013(07)04","volume":"68","author":"M Cruellas","year":"2013","unstructured":"Cruellas M, Viana V, Levy-Neto M, Souza F, Shinjo S. Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics. 2013;68(7):909\u201314.","journal-title":"Clinics"},{"issue":"9","key":"433_CR17","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","volume":"62","author":"L Christopher-Stine","year":"2010","unstructured":"Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum. 2010;62(9):2757\u201366.","journal-title":"Arthritis Rheum"},{"key":"433_CR18","doi-asserted-by":"crossref","unstructured":"Tansley S, Gunawardena H. The Evolving Spectrum of Polymyositis and Dermatomyositis\u2014Moving Towards Clinicoserological Syndromes: A Critical Review. Clin Rev Allergy Immunol [Internet]. 2013. [cited 2014 Mar 1]; Available from: http:\/\/link.springer.com\/ 10.1007\/s12016-013-8387-6","DOI":"10.1007\/s12016-013-8387-6"},{"issue":"3","key":"433_CR19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","volume":"61","author":"MFG Meulen Van der","year":"2003","unstructured":"Van der Meulen MFG, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, et al. Polymyositis: An overdiagnosed entity. Neurology. 2003;61(3):316\u201321.","journal-title":"Neurology"},{"key":"433_CR20","unstructured":"Milisenda JC, Selva-O\u2019Callaghan A, Grau JM. The diagnosis and classification of polymyositis. J Autoimmun [Internet]. 2014 [cited 2014 Mar 1]; Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841114000286"},{"issue":"4","key":"433_CR21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacl.2011.05.005","volume":"5","author":"LJ Harris","year":"2011","unstructured":"Harris LJ, Thapa R, Brown M, Pabbathi S, Childress RD, Heimberg M, et al. Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia. J Clin Lipidol. 2011;5(4):299\u2013307.","journal-title":"J Clin Lipidol"},{"issue":"6","key":"433_CR22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","volume":"19","author":"E Bruckert","year":"2006","unstructured":"Bruckert E, Hayem G, Dejager S, Yau C, B\u00e9gaud B. Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients \u2014The PRIMO Study. Cardiovasc Drugs Ther. 2006;19(6):403\u201314.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"8","key":"433_CR23","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.amjcard.2005.12.010","volume":"97","author":"M Law","year":"2006","unstructured":"Law M, Rudnicka AR. Statin Safety: A Systematic Review. Am J Cardiol. 2006;97(8):S52\u201360.","journal-title":"Am J Cardiol"},{"issue":"21","key":"433_CR24","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1001\/jama.292.21.2585","volume":"292","author":"DJ Graham","year":"2004","unstructured":"Graham DJ, Staffa JA, Shatin D, et al. INcidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA. 2004;292(21):2585\u201390.","journal-title":"JAMA"},{"issue":"6","key":"433_CR25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/BOR.0b013e32833f0fc7","volume":"22","author":"A Mammen","year":"2010","unstructured":"Mammen A, Amato AA. Statin myopathy: a review of recent progress. Curr Opin Rheumatol. 2010;22(6):644\u201350.","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"433_CR26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.coph.2007.12.010","volume":"8","author":"P Sirvent","year":"2008","unstructured":"Sirvent P, Mercier J, Lacampagne A. New insights into mechanisms of statin-associated myotoxicity. Curr Opin Pharmacol. 2008;8(3):333\u20138.","journal-title":"Curr Opin Pharmacol"},{"key":"433_CR27","doi-asserted-by":"crossref","unstructured":"SLCO1B1 Variants and Statin-Induced Myopathy \u2014 A Genomewide Study. N Engl J Med. 2008;359(8):789\u201399.","DOI":"10.1056\/NEJMoa0801936"},{"issue":"2","key":"433_CR28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","volume":"41","author":"P Grable-Esposito","year":"2010","unstructured":"Grable-Esposito P, Katzberg HD, Greenberg SA, Srinivasan J, Katz J, Amato AA. Immune-mediated necrotizing myopathy associated with statins. Muscle Nerve. 2010;41(2):185\u201390.","journal-title":"Muscle Nerve"},{"issue":"2","key":"433_CR29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nmd.2006.10.007","volume":"17","author":"M Needham","year":"2007","unstructured":"Needham M, Fabian V, Knezevic W, Panegyres P, Zilko P, Mastaglia FL. Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscul Disord. 2007;17(2):194\u2013200.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"433_CR30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/anr.1780320324","volume":"32","author":"J Goldman","year":"1989","unstructured":"Goldman J, Fishman A, Lee J, Johnson R. The role of cholesterol-lowering agents in drug-induced rhabdomyolysis and polymyositis. Arthritis Rheum. 1989;32(3):358\u20139.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"433_CR31","first-page":"649","volume":"327","author":"B Schalke","year":"1992","unstructured":"Schalke B, Schmidt B, Toyka K, Hartung H. Pravastatin-Associated Inflammatory Myopathy. N Engl J Med. 1992;327(9):649\u201350.","journal-title":"N Engl J Med"},{"issue":"9065","key":"433_CR32","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(05)61628-5","volume":"349","author":"N Giordano","year":"1997","unstructured":"Giordano N, Senesi M, Mattii G, Battisti E, Villanova M, Gennari C. Polymyositis associated with simvastatin. Lancet. 1997;349(9065):1600\u20131.","journal-title":"Lancet"},{"issue":"3","key":"433_CR33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","volume":"63","author":"AL Mammen","year":"2011","unstructured":"Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum. 2011;63(3):713\u201321. This study identified the autoantigen involved in statin-associated autoimmune myopathy and provided a mechanistic link between the drug and development of sustained autoimmunity.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"433_CR34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/acr.20662","volume":"64","author":"AL Mammen","year":"2012","unstructured":"Mammen AL, Pak K, Williams EK, Brisson D, Coresh J, Selvin E, et al. Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Arthritis Care Res. 2012;64(2):269\u201372. This study demonstrated that anti-HMGCR is infrequently seen in patients who take statins, including those with self-limited statin intolerance, and is specific for an autoimmune myopathy.","journal-title":"Arthritis Care Res"},{"key":"433_CR35","doi-asserted-by":"crossref","unstructured":"Mammen AL, Gaudet D, Brisson D, Christopher-Stine L, Lloyd TE, Leffell MS, et al. Increased frequency of DRB1*11:01 in anti-HMG-CoA reductase-associated autoimmune myopathy. Arthritis Care Res. 2012;1233\u20137. This study identified class II HLA loci that confer susceptibility to and protection from anti-HMGCR myopathy.","DOI":"10.1002\/acr.21671"},{"issue":"12","key":"433_CR36","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/art.34673","volume":"64","author":"JL Werner","year":"2012","unstructured":"Werner JL, Christopher-Stine L, Ghazarian SR, Pak KS, Kus JE, Daya NR, et al. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Rheum. 2012;64(12):4087\u201393.","journal-title":"Arthritis Rheum"},{"issue":"22","key":"433_CR37","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1056\/NEJMcpc1208147","volume":"367","author":"RC Cabot","year":"2012","unstructured":"Cabot RC, Harris NL, Rosenberg ES, Shepard J-AO, Cort AM, Ebeling SH, et al. Case 37-2012: A 21-Year-Old Man with Fevers, Arthralgias, and Pulmonary Infiltrates. N Engl J Med. 2012;367(22):2134\u201346.","journal-title":"N Engl J Med"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-014-0433-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-014-0433-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-014-0433-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T23:52:21Z","timestamp":1598053941000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-014-0433-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,5]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["433"],"URL":"https:\/\/doi.org\/10.1007\/s11926-014-0433-8","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,5]]},"article-number":"433"}}